PACAP27 induces migraine-like attacks in migraine patients.
Adolescent
Adult
Blood Flow Velocity
/ drug effects
Cross-Over Studies
Double-Blind Method
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Migraine without Aura
/ chemically induced
Pituitary Adenylate Cyclase-Activating Polypeptide
/ administration & dosage
Vasodilator Agents
/ administration & dosage
Young Adult
Pituitary adenylate cyclase-activating polypeptide
cyclic adenosine monophosphate
flushing
headache
migraine
vasoactive intestinal polypeptide
Journal
Cephalalgia : an international journal of headache
ISSN: 1468-2982
Titre abrégé: Cephalalgia
Pays: England
ID NLM: 8200710
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
pubmed:
14
7
2019
medline:
1
4
2021
entrez:
14
7
2019
Statut:
ppublish
Résumé
Pituitary adenylate cyclase-activating polypeptide (PACAP) is found in two functional isoforms, namely PACAP38 and PACAP27. The migraine-inducing properties of PACAP38 are well studied. However, it is not known whether the lesser-known and under-studied protein isoform, PACAP27, can also induce migraine attacks. Here, we studied the effect of human PACAP27 infusion on induction of migraine in a provocation model. In a crossover study, 20 migraine without aura patients were randomly assigned to receive human PACAP27 (10 picomol/kg/min) or saline (placebo) infusion over 20 min. We recorded the migraine and associated symptoms. All patients completed the study. PACAP27 provoked migraine-like attacks in 11 patients (55%) and two developed attacks after placebo (10%) ( PACAP27 triggers migraine attacks without aura. These novel data strengthen the role of PACAP and its receptors in migraine pathogenesis.
Identifiants
pubmed: 31299857
doi: 10.1177/0333102419864507
doi:
Substances chimiques
Pituitary Adenylate Cyclase-Activating Polypeptide
0
Vasodilator Agents
0
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM